688575 Stock Overview
Researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Shenzhen YHLO Biotech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.22 |
| 52 Week High | CN¥28.27 |
| 52 Week Low | CN¥17.45 |
| Beta | 0.66 |
| 11 Month Change | -8.12% |
| 3 Month Change | -2.15% |
| 1 Year Change | -21.97% |
| 33 Year Change | -20.29% |
| 5 Year Change | n/a |
| Change since IPO | -60.14% |
Recent News & Updates
We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings
Nov 06
Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch
Nov 04Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)
Oct 31Recent updates
We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings
Nov 06Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch
Nov 04Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)
Oct 31Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return
Oct 12Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings
Aug 30Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?
Jul 18Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing
May 23Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 01There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital
Mar 19Shareholder Returns
| 688575 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -1.8% | -2.4% | -3.4% |
| 1Y | -22.0% | -5.5% | 6.1% |
Return vs Industry: 688575 underperformed the CN Medical Equipment industry which returned -5.5% over the past year.
Return vs Market: 688575 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 688575 volatility | |
|---|---|
| 688575 Average Weekly Movement | 7.8% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 688575 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688575's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,776 | Yongbo Song | www.szyhlo.com |
Shenzhen YHLO Biotech Co., Ltd. researches, develops, produces, sells, and services in vitro diagnostic instruments and reagents in China and internationally. The company offers automatic chemiluminescence immunoassay analyzers, chemiluminescent immunoassay analyzers, and iModule automatic immunoassay pipelines; and automatic immunofluorescence staining systems, automatic immunofluorescence analysis systems, automatic western blotting analyzers, auto automatic western blot analyzers, and automatic western blotting instruments. It also provides UNION new generation immune analyzers; dry fluorescence immunoassay analyzers, vision automatic dynamic ESR analyzers, and vision dynamic ESR analyzers; and automated sample processing systems and intelligent laboratory information systems, as well as antigen detection and test kits.
Shenzhen YHLO Biotech Co., Ltd. Fundamentals Summary
| 688575 fundamental statistics | |
|---|---|
| Market cap | CN¥10.37b |
| Earnings (TTM) | CN¥288.64m |
| Revenue (TTM) | CN¥1.90b |
35.9x
P/E Ratio5.5x
P/S RatioIs 688575 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688575 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.90b |
| Cost of Revenue | CN¥734.78m |
| Gross Profit | CN¥1.17b |
| Other Expenses | CN¥878.60m |
| Earnings | CN¥288.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.51 |
| Gross Margin | 61.37% |
| Net Profit Margin | 15.18% |
| Debt/Equity Ratio | 32.4% |
How did 688575 perform over the long term?
See historical performance and comparison